Literature DB >> 21454880

Therapy-related acute promyelocytic leukemia.

Farhad Ravandi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454880      PMCID: PMC3069223          DOI: 10.3324/haematol.2011.041970

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  Insights into leukemogenesis from therapy-related leukemia.

Authors:  Jens Pedersen-Bjergaard
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

2.  Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia.

Authors:  Elihu Estey; Guillermo Garcia-Manero; Alessandra Ferrajoli; Stefan Faderl; Srdan Verstovsek; Dan Jones; Hagop Kantarjian
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

3.  Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem.

Authors:  Roberto Latagliata; Maria Concetta Petti; Susanna Fenu; Marco Mancini; Maria Antonietta Aloe Spiriti; Massimo Breccia; Gregorio A Brunetti; Giuseppe Avvisati; Francesco Lo Coco; Franco Mandelli
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

4.  DNA topoisomerase II in therapy-related acute promyelocytic leukemia.

Authors:  Anita R Mistry; Carolyn A Felix; Ryan J Whitmarsh; Annabel Mason; Andreas Reiter; Bruno Cassinat; Anne Parry; Christoph Walz; Joseph L Wiemels; Mark R Segal; Lionel Adès; Ian A Blair; Neil Osheroff; Andrew J Peniket; Marina Lafage-Pochitaloff; Nicholas C P Cross; Christine Chomienne; Ellen Solomon; Pierre Fenaux; David Grimwade
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

5.  Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy.

Authors:  A Ghavamzadeh; K Alimoghaddam; S H Ghaffari; S Rostami; M Jahani; R Hosseini; A Mossavi; E Baybordi; A Khodabadeh; M Iravani; B Bahar; Y Mortazavi; M Totonchi; N Aghdami
Journal:  Ann Oncol       Date:  2005-10-14       Impact factor: 32.976

Review 6.  The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation.

Authors:  J Pedersen-Bjergaard; J D Rowley
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

7.  Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.

Authors:  Alessandro Pulsoni; Livio Pagano; Francesco Lo Coco; Giuseppe Avvisati; Luca Mele; Eros Di Bona; Rosangela Invernizzi; Franco Leoni; Filippo Marmont; Alfonso Mele; Lorella Melillo; Anna Maria Nosari; Enrico Maria Pogliani; Marco Vignetti; Giuseppe Visani; Vittorina Zagonel; Giuseppe Leone; Franco Mandelli
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

8.  Therapy-related acute promyelocytic leukemia.

Authors:  M Beaumont; M Sanz; P M Carli; F Maloisel; X Thomas; L Detourmignies; A Guerci; N Gratecos; C Rayon; J San Miguel; J Odriozola; J Y Cahn; F Huguet; A Vekhof; A Stamatoulas; H Dombret; F Capote; J Esteve; A M Stoppa; P Fenaux
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

9.  Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis.

Authors:  Syed Khizer Hasan; Ashley N Mays; Tiziana Ottone; Antonio Ledda; Giorgio La Nasa; Chiara Cattaneo; Erika Borlenghi; Lorella Melillo; Enrico Montefusco; José Cervera; Christopher Stephen; Gnanam Satchi; Anne Lennard; Marta Libura; Jo Ann W Byl; Neil Osheroff; Sergio Amadori; Carolyn A Felix; Maria Teresa Voso; Wolfgang R Sperr; Jordi Esteve; Miguel A Sanz; David Grimwade; Francesco Lo-Coco
Journal:  Blood       Date:  2008-07-23       Impact factor: 22.113

10.  All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.

Authors:  Zhi-Xiang Shen; Zhan-Zhong Shi; Jing Fang; Bai-Wei Gu; Jun-Min Li; Yong-Mei Zhu; Jing-Yi Shi; Pei-Zheng Zheng; Hua Yan; Yuan-Fang Liu; Yu Chen; Yang Shen; Wen Wu; Wei Tang; Samuel Waxman; Hugues De Thé; Zhen-Yi Wang; Sai-Juan Chen; Zhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

View more
  2 in total

Review 1.  The evolving challenge of therapy-related myeloid neoplasms.

Authors:  Jane E Churpek; Richard A Larson
Journal:  Best Pract Res Clin Haematol       Date:  2013-10-01       Impact factor: 3.020

2.  Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia.

Authors:  Hikaru Hattori; Yuichi Ishikawa; Naomi Kawashima; Akimi Akashi; Yohei Yamaguchi; Yasuhiko Harada; Daiki Hirano; Yoshiya Adachi; Kotaro Miyao; Yoko Ushijima; Seitaro Terakura; Tetsuya Nishida; Tadashi Matsushita; Hitoshi Kiyoi
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.